Pelthos Therapeutics Inc — Cash Flow (NYSE:PTHS)

Financials

Cash from operating activities -981.03 K-5.79 M -17.01 M Cash from investing activities —— — Cash from financing activities 1.02 M6.21 M 27.25 M Free cash flow -981.03 K-5.79 M -17.01 M